Rynel Clifton Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.30 M
- Revenue Growth 16.07%
- Profit Growth 15.71%
- Ebitda 261.13%
- Net Worth 25.86%
- Total Assets 12.42%
About Rynel Clifton Pharma
Rynel Clifton Pharma Private Limited (RCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2013 and has a history of 11 years and 11 months. Its registered office is in Hisar, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.30 M.
Ashwini Kumar and Rajiv Chawla serve as directors at the Company.
Company Details
- Location
Hisar, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33110HR2013PTC049548
- Company No.
049548
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
What products or services does Rynel Clifton Pharma Private Limited offer?
Rynel Clifton Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Eye Drops, Pharma & Bioanalytical Services, PCD Pharma Franchise.
Rynel Clifton Pharma Private Limited
Explore comprehensive data for Rynel Clifton Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Rynel Clifton Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwini Kumar  | Director | 14-Jun-2013 | Current |
| Rajiv Chawla | Director | 14-Jun-2013 | Current |
Financial Performance of Rynel Clifton Pharma.
Rynel Clifton Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.07% increase. The company also saw a substantial improvement in profitability, with a 15.71% increase in profit. The company's net worth Soared by an impressive increase of 25.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rynel Clifton Pharma?
In 2021, Rynel Clifton Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Grevis Pharmaceuticals Private LimitedAshwini Kumar is a mutual person
Eyeris Vision Care Private LimitedRajiv Chawla is a mutual person
Charges (Loans)
Open Charges
₹2.30 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2014 | State Bank Of India | ₹2.30 M | Open |
How Many Employees Work at Rynel Clifton Pharma?
Unlock and access historical data on people associated with Rynel Clifton Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rynel Clifton Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rynel Clifton Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Rynel Clifton Pharma
Recent activity within the organization
- Annual General Meeting
Rynel Clifton Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Rynel Clifton Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with State Bank Of India amounted to Rs. 2.30 M with Charge ID 10543500 was registered on 15 Dec 2014.
- Director Appointment
Ashwini Kumar was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 11 months .
- Director Appointment
Rajiv Chawla was appointed as a Director was appointed as a Director on 14 Jun 2013 & has been associated with this company since 11 years 11 months .
- Company Incorporation
Rynel Clifton Pharma Private Limited was registered on 14 Jun 2013 with Roc Delhi & aged 11 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Rynel Clifton Pharma Private Limited?
Rynel Clifton Pharma Private Limited was incorporated on 14 Jun 2013.
What is authorized share capital and paid-up capital of Rynel Clifton Pharma Private Limited?
The authorized share capital of Rynel Clifton Pharma Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Rynel Clifton Pharma Private Limited?
Currently 2 directors are associated with Rynel Clifton Pharma Private Limited.
- Ashwini Kumar
- Rajiv Chawla
What is the registered address of Rynel Clifton Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Rynel Clifton Pharma Private Limited is Dss 65 Commercial Complex Kaimary Road, Sector-15A India, Hisar, Haryana, 125001.
What is the corporate identification number (CIN) and company number of Rynel Clifton Pharma Private Limited?
The corporate identification number (CIN) of Rynel Clifton Pharma Private Limited is U33110HR2013PTC049548 and the company number is 049548 as per Ministry of Corporate Affairs (MCA).
What is the official website of Rynel Clifton Pharma Private Limited?
The Official website of Rynel Clifton Pharma Private Limited is https://www.rynelcliftonpharma.com
What has been the recent revenue trend for Rynel Clifton Pharma Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Rynel Clifton Pharma Private Limited has risen by 16.07%.
What change has been observed in the net worth of Rynel Clifton Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Rynel Clifton Pharma Private Limited has experienced an upsurge of 25.86%.
What are the total open charges for Rynel Clifton Pharma Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Rynel Clifton Pharma Private Limited amount to ₹ 2.30 M.
When was the last Balance Sheet of Rynel Clifton Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Rynel Clifton Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records